Related Experiment Video

Updated: Sep 3, 2025

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.6K

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology

Elena Arconada-Luque1, Jaime Jiménez-Suarez1, Raquel Pascual-Serra1

  • 1Laboratorio de Oncología Molecular, Unidad de Medicina Molecular, Centro Regional de Investigaciones Biomédicas, Unidad Asociada de Biomedicina UCLM, Unidad Asociada al CSIC, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.

Cancers
|July 27, 2022
PubMed

Insights

The study reveals that ERK5 (Extracellular signal-regulated kinase 5) is upregulated in sarcomas and crucial for tumor growth. Inhibiting ERK5 significantly reduces sarcoma progression and impacts key biological processes, suggesting a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sarcomas are complex tumors with poorly understood molecular mechanisms.
  • The role of Extracellular signal-regulated kinase 5 (ERK5) in sarcoma development is largely uninvestigated.

Purpose of the Study:

  • To elucidate the function of ERK5 in sarcoma pathology.
  • To identify potential therapeutic targets for sarcoma treatment.

Main Methods:

  • Utilized a murine 3-methyl-cholanthrene (3MC)-induced sarcoma model.
  • Employed RNA sequencing (RNAseq) for transcriptomic profiling.
  • Used short hairpin RNAs (shRNAs) to abrogate gene expression.

Main Results:

  • 3-methyl-cholanthrene (3MC) induced pleomorphic sarcomas with increased ERK5 expression, also observed in human muscle sarcomas.
  • Abrogation of ERK5 (encoded by Mapk7) in cell lines reduced in vitro growth, colony formation, and in vivo tumor growth.
  • RNAseq revealed deregulated gene expression in angiogenesis, migration, and motility upon ERK5 abrogation, correlating with better prognosis in human sarcomas.
  • Identified the ERK5-KLF2 axis as a key determinant in sarcoma biology.

Conclusions:

  • ERK5 plays a significant role in sarcoma progression and is a potential therapeutic target.
  • The ERK5-KLF2 signaling pathway is critical for sarcoma biology and warrants further investigation in human pathology.
Keywords:
3-methyl-cholanthreneERK5KLF2MAPK7leiomyosarcomarhabdomyosarcomasoft tissue sarcoma

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.4K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K